Bank of New York Mellon Corp - ABCELLERA BIOLOGICS INC ownership

ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 118 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 1.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ABCELLERA BIOLOGICS INC
ValueSharesWeighting
Q1 2023$5,941,362
-26.2%
787,979
-0.9%
0.00%
-50.0%
Q4 2022$8,054,211
+5.6%
795,085
+3.1%
0.00%0.0%
Q3 2022$7,627,000
+3.9%
771,244
+11.8%
0.00%0.0%
Q2 2022$7,343,000
+1181.5%
689,538
+2309.9%
0.00%
Q3 2021$573,000
-70.7%
28,613
-67.8%
0.00%
Q2 2021$1,957,00088,9710.00%
Other shareholders
ABCELLERA BIOLOGICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Founders Fund VII Management, LLC 3,773,530$37,320,00092.58%
Gruss & Co., LLC 308,570$3,052,00026.27%
Founders Fund Growth Management, LLC 407,017$4,025,00011.55%
Belmont Capital, LLC 510,000$5,044,0005.95%
HARVARD MANAGEMENT CO INC 4,105,095$40,599,0005.05%
GUARDIAN CAPITAL ADVISORS LP 3,736,414$40,129,0005.01%
Intellectus Partners, LLC 1,091,505$10,795,0003.84%
ArchPoint Investors 617,213$6,104,0002.49%
BRANDYWINE MANAGERS, LLC 56,976$563,0001.85%
Casdin Capital, LLC 1,650,000$16,319,0001.07%
View complete list of ABCELLERA BIOLOGICS INC shareholders